FDA Eases Restrictions on Unapproved Peptides: Risks and Opportunities for Pharmacies

The FDA is moving forward with a plan to facilitate access to unapproved peptides, despite internal scientists concerns about their safety and efficacy. The...
Read on GoYou.it (goyou.it/en/tecnologia/2026/10/17/fda-eases-re…)